Is an oral antiviral drug that contains Molnupiravir 200 mg for emergency treatment of mild-moderate covid-19.

• FDA oral approved antiviral drug for Covid-19.
• Convenient short-term treatment (5 days).
• Decreases the risk of hospitalization and mortality.
• No dose adjustment is recommended in patient with hepatic and renal impairment or based on age and body mass index (BMI).